Metabolic profiles in laryngeal cancer defined two distinct molecular subtypes with divergent prognoses
BackgroundLaryngeal cancer (LCA) is the second most common type of head and neck malignancy, characterized by high recurrence rates and poor overall survival (OS). However, progress in curing LCA through molecular-targeted diagnostics and therapies is …